Effect of haptoglobin on the metabolism of vitamin C

American Journal of Clinical Nutrition

Volumn 66, Issue 3, 1997, Pages 606-610

  Langlois, Michel R ^a   Delanghe, Joris R ^a   De Buyzere, Marc L ^a   Bernard, Dirk R ^a   Ouyang, Jin ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Acute phase protein; Antioxidants; Haptoglobin; Hemoglobin catalyzed oxidation; Humans; L ascorbic acid; Vitamin C

Indexed keywords

ACUTE PHASE PROTEIN; ANTIOXIDANT; ASCORBIC ACID; HAPTOGLOBIN;

ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; DRUG EFFECT; DRUG STABILITY; HUMAN; HUMAN CELL; IRON BINDING CAPACITY; LIPID OXIDATION; LIVER CELL; VITAMIN METABOLISM;

EID: 0030813430     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.3.606     Document Type: Article

References (32)

1. Bowman BH. Haptoglobin. In: Bowman BH, ed. Hepatic plasma proteins. San Diego: Academic Press, 1993:159-67.
2. Smithies O. Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults. Biochem J 1955;61:629-41.
3. Lange V. Der Haptoglobin Polymorphismus-nicht nur eine genetische Markierungshilfe. (The haptoglobin polymorphism - not just a genetic forensic tool.) Anthrop Anzeiger 1992;50:281-302 (in German).
4. Langlois M, Delanghe J. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-600.
5. Gutteridge JMC. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 1987;917:219-23.
6. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995;41:1819-28.
7. Kino J, Tsunoo H, Higa Y, Takami M. Hemoglobin-haptoglobin receptor in rat plasma membrane. J Biol Chem 1980;255:9616-20.
8. Delanghe J, Duprez D, De Buyzere M, et al. Haptoglobin polymorphism and complications in established essential arterial hypertension. J Hypertens 1993;11:861-7.
9. Delanghe J, Van Acker J, Hemmer R, Van der Groen G, Van Wanzeele F, Verhofstede K. Haptoglobin polymorphism and progression of human immune deficiency virus infection. Proceedings of the XVI International Congress of Clinical Chemistry. London: Association of Clinical Biochemists, 1996.
10. Frei B, England L, Ames BN. Ascorbic acid is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 1989;86:6377-81.
11. Niki E. Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am J Clin Nutr 1991;54(suppl):1119S-24S.
12. Frei B. Ascorbic acid protects lipids in human plasma and low density lipoprotein against oxidative modification. Am J Clin Nutr 1991;54(suppl):1113S-8S.
13. Jialal I, Vega GL, Grundy SM. Physiologic levels of ascorbic acid inhibit the oxidative modification of low density lipoproteins. Atherosclerosis 1990;82:185-91.
14. Retsky KL, Freeman MW, Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. J Biol Chem 1993;268:1304-9.
15. Retsky KL, Frei B. Vitamin C prevents metal-ion dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochim Biophys Acta 1995;1257:279-87.
16. Jialal I, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem 1996;42:498-506.
17. Stadtman ER. Ascorbic acid and oxidative inactivation of proteins. Am J Clin Nutr 1991;54(suppl):1125S-8S.
18. Sadrzadeh SMH, Eaton JW. Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest 1988;82:1510-5.
19. Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996;63:760-5.
20. Goldstein IM, Kaplan HB, Edelson HS, Weissmann G. Ceruloplasmin - a scavenger of superoxide anion radicals. J Biol Chem 1979;254:4040-5.
21. Beutler HO. L-ascorbate and L-dehydroascorbate. In: Bergmeier HU, ed. Methods of enzymatic analysis. Vol 4. 3rd ed. Weinheim, Germany: Verlag Chemie 1984:376-85.
22. Fink PC, Roemer M, Haeckel R, et al. Measurement of proteins with the Behring nephelometer: a multicentre evaluation. J Clin Chem Clin Biochem 1989;27:261-76.
23. Whicher JT, Ritchie RF, Johnson AM, et al. A new international reference preparation for proteins in human serum (RPPHS 5). Clin Chem 1994;40:934-8.
24. Burtis CA, Ashwood ER. Tietz textbook of clinical chemistry. 2nd ed. Philadelphia: WB Saunders, 1994.
25. Rice-Evans C, Miller N. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994;234:279-93.
26. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 2nd ed. Oxford, United Kingdom: Oxford University Press, 1989.
27. Jacob RA, Burri BJ. Oxidative damage and defense. Am J Clin Nutr 1996;63(suppl):985S-90S.
28. Delanghe J, Gambier B, De Buyzere M, et al. Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery. Acta Cardiol 1994;49:66.
29. Wong GHW, McHugh T, Weber R, Goeddel DV. Tumor necrosis factor ex selectively sensitizes human immunodeficiency virus infected cells to heat and radiation. Proc Natl Acad Sci U S A 1991;88:4372-6.
30. Schreck R, Pieber P, Bauerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
31. Harakeh S, Jariwalla RJ, Pauling L. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Natl Acad Sci U S A 1990;87:7245-9.
32. Harakeh S, Jariwalla RJ. Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells. Am J Clin Nutr 1991;54(suppl):1231S-5S.